Idiopathic pulmonary arterial hypertension: An avian model for plexogenic arteriopathy and serotonergic vasoconstriction

Journal of Pharmacological and Toxicological Methods

Volumn 63, Issue 3, 2011, Pages 283-295

  Wideman Jr , Robert F ^a   Hamal, Krishna R ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Animal model; Domestic fowl (chickens Gallus gallus domesticus); Lungs; Microparticle injection method; Pathology; Plexiform lesions; Pulmonary hypertension; Serotonin

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2; ENDOTHELIN 1; SEROTONIN; SEROTONIN TRANSPORTER; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ARTERY DISEASE; ARTICLE; CELL PROLIFERATION; CHICKEN; COMPARATIVE ANATOMY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOMESTIC FOWL; EXPERIMENTAL MODEL; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; NONHUMAN; PROTEIN EXPRESSION; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; SEROTONIN RELEASE; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM;

ANIMALS; ARTERIOLES; CHICKENS; DISEASE MODELS, ANIMAL; FEMALE; HYPERTENSION, PULMONARY; LUNG; MALE; PULMONARY ARTERY; SEROTONIN; TUNICA INTIMA; VASOCONSTRICTION;

ANIMALIA; AVES; GALLUS GALLUS;

EID: 79954625831     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2011.01.002     Document Type: Article

References (218)

1. Abdalla M.A., King A.S. The functional anatomy of the pulmonary circulation of the domestic fowl. Respiration Physiology 1975, 23:267-290.
2. Abe K., Toba M., Alzoubi A., Ito M., Fagan K.A., Cool C.D., et al. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension. Circulation 2010, 121:2747-2754.
3. Abenhaim L., Moride Y., Brenot F., Rich S., Benichou J., Kurz X., et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. The New England Journal of Medicine 1996, 335:609-616.
4. Aird W.C. Endothelial cell heterogeneity. Critical Care Medicine 2003, 31:S221-S230.
5. Albada M.E., Schoemaker R.G., Kemna M.S., Cromme-Dijkhuis A.H., Van Veghel R., Berger R.M.F. The role of increased pulmonary blood flow in pulmonary hypertension. The European Respiratory Journal 2005, 26:487-493.
6. Anthony N.B., Balog J.M., Hughes J.D., Stamps L., Cooper M.A., Kidd B.D., et al. Genetic selection of broiler lines that differ in their ascites susceptibility 1. Selection under hypobaric conditions. Proceedings of 13th European Symposium on Poultry Nutrition, Blankenberge, Belgium 2001, 327-328.
7. Archer S., Rich S. Primary pulmonary hypertension: A vascular biology and translational " work in progress". Circulation 2000, 102:2781-2791.
8. + channels in resistance pulmonary arteries explain regional heterogeneity in hypoxic pulmonary vasoconstriction: Ionic diversity in smooth muscle cells. Circulation Research 2004, 95:308-318.
9. Balog J.M. Ascites syndrome (pulmonary hypertension syndrome) in broiler chickens: Are we seeing the light at the end of the tunnel?. Avian and Poultry Biology Reviews 2003, 14:99-126.
10. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
11. Barst R.J. Pharmacologically induced pulmonary vasodilation in children and young adults with primary pulmonary hypertension. Chest 1986, 89:497-503.
12. Berger R.M., Geiger R., Hess J., Bogers A.J.J.C., Mooi W.I. Altered arterial expression patterns of inducible and endothelial nitric oxide synthase in pulmonary plexogenic arteriopathy caused by congenital heart disease. American Journal of Respiratory and Critical Care Medicine 2001, 163:1493-1499.
13. Botney M.D. Role of hemodynamics in pulmonary vascular remodeling. American Journal of Respiratory and Critical Care Medicine 1999, 159:361-364.
14. Bowen O.T., Erf G.F., Anthony N.B., Wideman R.F. Pulmonary hypertension triggered by lipopolysaccharide (LPS) in ascites-susceptible and -resistant broilers is not amplified by aminoguanidine, a specific inhibitor of inducible nitric oxide synthase (iNOS). Poultry Science 2006, 85:528-536.
15. Bowen O.T., Wideman R.F., Anthony N.B., Erf G.F. Variation in the pulmonary hypertensive responsiveness of broilers to lipopolysaccharide (LPS) and innate variation in nitric oxide (NO) production by mononuclear cells. Poultry Science 2006, 85:1349-1363.
16. Brenot F., Hervé P., Petitpretz P. Primary pulmonary hypertension and the appetite suppressant fenfluramine. British Heart Journal 1993, 89:117-120.
17. Brenot F., Hervé P., Petitpretz P., Parent F., Duroux P., Simmoneu G. Primary pulmonary hypertension and fenfluramine use. British Heart Journal 1993, 70:537-541.
18. Brown R.E., Brain J.D., Wang N. The avian respiratory system: A unique model for studies of respiratory toxicosis and for monitoring air quality. Environmental Health Perspectives 1997, 105:188-200.
19. Budhiraja R., Tuder R.M., Hassoun P.M. Endothelial dysfunction in pulmonary hypertension. Circulation 2004, 109:159-165.
20. Caslin A.W., Heath D., Madden B., Yacoub M., Gosney J.R., Smith P. The histopathology of 36 cases of plexogenic pulmonary arteriopathy. Histopathology 1990, 16:9-19.
21. Celada P., Martin F., Artigas F. Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain, and lung tissue. Life Sciences 1994, 55:1237-1243.
22. Chapman M.E., Taylor R.L., Wideman R.F. Analysis of plasma serotonin levels and hemodynamic responses following chronic serotonin infusion in broilers challenged with bacterial lipopolysaccharide and microparticles. Poultry Science 2008, 87:116-124.
23. Chapman M.E., Wideman R.F. Pulmonary wedge pressures confirm pulmonary hypertension in broilers is initiated by an excessive pulmonary arterial (precapillary) resistance. Poultry Science 2001, 80(4):468-473.
24. Chapman M.E., Wideman R.F. Hemodynamic responses of broiler pulmonary vasculature to intravenously infused serotonin. Poultry Science 2002, 81:231-238.
25. Chapman M.E., Wideman R.F. Evaluation of the serotonin receptor blockers ketanserin and methiothepin on the pulmonary hypertensive responses of broilers to intravenously infused serotonin. Poultry Science 2006, 85:777-786.
26. Chapman M.E., Wideman R.F. Evaluation of the serotonin receptor blocker Methiothepin in broilers injected intravenously with lipopolysaccharide and microparticles. Poultry Science 2006, 85:2222-2230.
27. Chazova I., Loyd J.E., Zhdanov V.S., Newman J.H., Belenkov Y., Meyrick B. Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension. The American Journal of Pathology 1995, 146:389-397.
28. Choi D.S., Maroteaux L. Immunohistochemical localization of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain. Federation of European Biochemical Society Letters 1996, 391:45-51.
29. Cisar C.R., Balog J.M., Anthony N.B., Donoghue A.M. Sequence analysis of bone morphogenetic protein receptor type II mRNA from ascitic and nonascitic commercial broilers. Poultry Science 2003, 82:1494-1499.
30. Cisar C.R., Balog J.M., Okiomoto R., Anthony N.B., Donoghue A.M. The chicken bone morphogenetic protein receptor type II (BMPR2) gene maps to chromosome 7. Animal Genetics 2003, 34:475-476.
31. v1.5 channel internalization. Circulation Research 2006, 98:860-862.
32. Cool C.D., Groshong S.D., Oakey J., Voelkel N.F. Pulmonary hypertension: Cellular and molecular mechanisms. Chest 2005, 128:565-571.
33. Cool C.D., Kennedy D., Voelkel N.F., Tuder R.M. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Human Pathology 1997, 28:434-442.
34. Cool C.D., Stewart J.S., Werahera P., Miller G.J., Williams R.L., Voelkel N.F., et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of endothelial cell growth. The American Journal of Pathology 1999, 155:411-419.
35. Cueva S., Sillau H., Valenzuela A., Ploog H. High altitude induced pulmonary hypertension and right ventricular failure in broiler chickens. Research in Veterinary Science 1974, 16:370-374.
36. Dammann J.F., McEachen J.A., Thompson W.M., Smith R., Muller W.H. The regression of pulmonary vascular disease after the creation of pulmonary stenosis. The Journal of Thoracic and Cardiovascular Surgery 1961, 42:722-731.
37. De Jonghe F., Swinkels J. Selective serotonin reuptake inhibitors: Relevance to differences in their pharmacologic and clinical profiles. Central Nervous System Drugs 1997, 7:452-467.
38. Deeb N., Shlosberg A., Cahaner A. Genotype-by-environment interaction with broiler genotypes differing in growth rate. 4. Association between responses to heat stress and to cold-induced ascites. Poultry Science 2002, 81:1454-1462.
39. Demiryurek A.T., Wadsworth R.M., Kane K.A. Pharmacological evidence for the role of mediators in hypoxia-induced vasoconstriction in sheep isolated intrapulmonary artery rings. European Journal of Pharmacology 1991, 203:1-8.
40. Dorfmüller P., Perros F., Balabanian K., Humbert M. Inflammation in pulmonary arterial hypertension. The European Respiratory Journal 2003, 22:358-363.
41. Dorfmüller P., Zarka V., Durand-Gasselin I., Monti G., Balabanian K., Garcia G., et al. Chemokine RANTES in severe pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine 2002, 165:534-539.
42. Douglas J.G., Munro J.F., Kitchin A.H., Muir A.L., Proudfoot A.T. Pulmonary hypertension and fenfluramine. British Medical Journal 1981, 283:881-883.
43. Du L., Sullivan C.C., Chu D., Cho A., Kido J.M., Wolfe P.L., et al. Signaling molecules in nonfamilial pulmonary hypertension. The New England Journal of Medicine 2003, 348:500-509.
44. Duncker H.R. Structure of avian lungs. Respiratory Physiology 1972, 14:44-63.
45. Eddahibi S., Adnot S. Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: Lessons for the future in pathogenesis. Respiratory Research 2002, 3:9-13.
46. Eddahibi S., Adnot S. The serotonin pathway in pulmonary hypertension. Advances in Pulmonary Hypertension 2005, 4(1):20-23.
47. Eddahibi S., Adnot S., Frisdale E., Levame M., Hamon M., Raffestin B. Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. The Journal of Pharmacology and Experimental Therapeutics 2001, 297:148-154.
48. Eddahibi S., Chaouat A., Morrell N., Fadel E., Fuhrman C., Bugnet A.-S., et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003, 108:1839-1844.
49. Eddahibi S., Fabre V., Boni C., Martres M.P., Raffestein B., Harmon M., et al. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells - Relationship with the mitogenic action of serotonin. Circulation Research 1999, 84:329-336.
50. Eddahibi S., Guignabert C., Barlier-Mur A.-M., Dewachter L., Fadel E., Dartevelle P., et al. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension. Critical role for serotonin-induced smooth muscle hyperplasia. Circulation 2006, 113:1857-1864.
51. Eddahibi S., Hanoun N., Lanfumey L., Lesch K., Raffestin B., Harmon M., et al. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transported gene. The Journal of Clinical Investigation 2000, 105:1555-1562.
52. Eddahibi S., Humbert M., Fadel E., Raffestin B., Darmon M., Capron F., et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. The Journal of Clinical Investigation 2001, 108:1141-1150.
53. Eddahibi S., Morrell N., d'Ortho M.P., Naeije R., Adnot S. Pathobiology of pulmonary arterial hypertension. The European Respiratory Journal 2002, 20:1559-1572.
54. Eddahibi S., Raffestin B., Pham I., Launay J.M., Aegerter P., Sitbon M., et al. Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. The American Journal of Physiology 1997, 272:H1173-H1181.
55. Egermayer P., Town G.I., Peacock A.J. Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension. Thorax 1999, 54:161-168.
56. Engel G., Gothert M.K., Hoyer D., Schlicker E., Hillebrand K. Identity of inhibitory presynaptic 5-hydroxytryptamine autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn Schmiedeberg's Archives of Pharmacology 1986, 357:1-7.
57. Enkvetchakul B., Beasley J., Bottje W. Pulmonary arteriole hypertrophy in broilers with pulmonary hypertension syndrome (ascites). Poultry Science 1995, 74:1676-1682.
58. Fanburg B.L., Lee S.L. A new role for an old molecule: Serotonin as a mitogen. The American Journal of Physiology 1997, 272:L795-L806.
59. Farber H.W., Loscalzo J. Prothrombic hypertension mechanisms in primary pulmonary hypertension. The Journal of Laboratory and Clinical Medicine 1999, 134:561-566.
60. Firth A.L., Mandel J., Yuan J.X.J. Idiopathic pulmonary arterial hypertension. Disease Models and Mechanisms 2010, 3:268-278.
61. Frid M.G., Aldashev A.A., Dempsey E.C., Stenmark K.R. Smooth muscle cells isolated from discrete compartments of the mature vessel media exhibit unique phenotypes and distinct growth capabilities. Circulation Research 1997, 81:940-952.
62. Geiger R., Berger R.M., Hess J., Bogers A.J., Sharma H.S., Mooi W.J. Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease. The Journal of Pathology 2000, 191:202-207.
63. Giaid A., Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. The New England Journal of Medicine 1995, 333:214-221.
64. Giaid A., Yanagisawa M., Langleben D., Michael R.P., Levy R., Shennib H., et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. The New England Journal of Medicine 1993, 328:1732-1739.
65. Guignabert C., Izikki M., Tu L.I., Li Z., Zadigue P., Barlier-Mur A.-M., et al. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circulation Research 2006, 98:1323-1330.
66. Guignabert C., Raffestin B., Benferhat R., Raoul W., Zadigue P., Rideau D., et al. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation 2005, 111:2812-2819.
67. Gust R., Schuster D.P. Vascular remodeling in experimentally induced subacute canine pulmonary hypertension. Experimental Lung Research 2001, 27:1-12.
68. Hamal K.R., Wideman R., Anthony N., Erf G.F. Expression of inducible nitric oxide synthase in lungs of broiler chickens following intravenous cellulose microparticle injection. Poultry Science 2008, 87:636-644.
69. Hamal K.R., Wideman R.F., Anthony N.B., Erf G.F. Differential gene expression of pro-inflammatory chemokines and cytokines in lungs of ascites-resistant and -susceptible broiler chickens following intravenous cellulose microparticle injection. Veterinary Immunology and Immunopathology 2010, 133:250-255.
70. Hamal K.R., Wideman R.F., Anthony N.B., Erf G.F. Differential expression of vasoactive mediators in the microparticle challenged lungs of chickens that differ in susceptibility to pulmonary arterial hypertension. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 2010, 298:R235-R242.
71. Heath D., Edwards J.E. The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac defects. Circulation 1958, 18:533-547.
72. Heffner J.E., Repine J.E. Platelets. The lung: Scientific foundations 1997, 947-959. Lippincott-Raven, Philadelphia, PA. 2nd ed. R.G. Crystal, J.B. West, P.J. Barnes, E.R. Weibel (Eds.).
73. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 1996, 66:2621-2624.
74. Hernandez A. Hypoxic ascites in broilers: A review of several studies done in Colombia. Avian Disease 1987, 31:171-183.
75. Hervé P., Launay J.M., Scrobohaci M.L., Brenot F., Simonneau G., Petitpretz P., et al. Increased plasma serotonin in primary pulmonary hypertension. The American Journal of Medicine 1995, 99:249-254.
76. Hoeper M.M., Mayer E., Simonneau G., Rubin L.J. Chronic thromboembolic pulmonary hypertension. Circulation 2006, 113:2011-2020.
77. Huchzermeyer F.W., DeRuyck A.M.C. Pulmonary hypertension syndrome associated with ascites in broilers. The Veterinary Record 1986, 119:94.
78. Huchzermeyer F.W., DeRuyck A.M.C., Van Ark H. Broiler pulmonary hypertension syndrome. III. Commercial broiler strains differ in their susceptibility. Onderstepoort. Journal of Veterinary Research 1988, 55:5-9.
79. Humbert M., Morrell N.W., Archer S.L., Stenmark K.R., MacLean M.R., Lang I.M., et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. Journal of the American College of Cardiology 2004, 43:13S-24S.
80. Huxtable R.J. Activation and pulmonary toxicity of pyrrolizidine alkaloids. Pharmacology & Therapeutics 1990, 47:371-389.
81. Hyvelin J.-M., Howell K., Nichol A., Costello C.M., Preston R.J., McLoughlin P. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circulation Research 2005, 97:185-191.
82. Ivy D.D., McMurtry I.F., Colvin K., Imamura M., Oka M., Lee D.-S., et al. Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: A new model of severe pulmonary artery hypertension. Circulation 2005, 111:2988-2996.
83. Jones S.P., Greer J.J.M., Van Haperen R., Duncker D.J., de Crom R., Lefer D.J. Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:4891-4896.
84. Julian R.J. Pulmonary hypertension as a cause of right ventricular failure and ascites in broilers. Zootecnica International 1988, November, 11:58-62.
85. Julian R.J. Lung volume of meat-type chickens. Avian Disease 1989, 33:174-176.
86. Julian R.J. Ascites in poultry. Avian Pathology 1993, 22:419-454.
87. Keegan A., Morecroft I., Smillie D., Hicks M.N., MacLean M.R. Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: Converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935. Circulation Research 2001, 89:1231-1239.
88. 2+ and permeability. The American Journal of Physiology 1998, 274:L810-L819.
89. Kentera D., Susic D., Veljkovic V., Tukacovic G., Koko V. Pulmonary artery pressure in rats with hereditary platelet function defect. Respiration 1988, 54:110-114.
90. Kuruma I., Okada T., Kataoka K., Sorimachi M. Ultrastructural observation of 5-hydroxytryptamine-storing granules in the domestic fowl thrombocytes. Zeitschrift Fuer Zellforschung Und Mikroskopische Anatomie 1970, 108:268-281.
91. Lacoste-Eleaume A.S., Bleux C., Quere P., Coudert F., Corbel C., Kanellopoulos-Langevin C. Biochemical and functional characterization of an avian homolog of the integrin GPIIb-IIIa present on chicken thrombocytes. Experimental Cell Research 1994, 213:198-209.
92. Lame M.W., Jones A.D., Wilson D.W., Dunston S.K., Segall H.J. Protein targets of monocrotaline pyrrole in pulmonary artery endothelial cells. The Journal of Biological Chemistry 2000, 275:29091-29099.
93. Launay J.M., Hervé P., Peoc'h K.K., Tournois C., Callebert J., Nebigil C.G., et al. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nature Medicine 2002, 8:1129-1135.
94. Lawrie A., Spiekerkoetter E., Martinez E.C., Ambartsumian N., Sheward W.J., MacLean M.R., et al. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circulation Research 2005, 97:227-235.
95. Le Cras T.D., Kim D.H., Gebb S., Markham N.E., Shannon J.M., Tuder R.M., et al. Abnormal lung growth and the development of pulmonary hypertension in the fawn-hooded rat. The American Journal of Physiology 1999, 277:L709-L718.
96. Lee S.L., Fanburg B.L. Serotonin uptake by bovine pulmonary artery endothelial cells in culture I. Characterization. American Journal of Physiology 1986, 250:C761-C765.
97. Lee S.L., Fanburg B.L. Serotonin uptake by bovine pulmonary artery endothelial cells in culture II. Stimulation by hypoxia. The American Journal of Physiology 1986, 250:C766-C770.
98. Lee S.L., Fanburg B.L. Glycolytic activity and enhancement of serotonin uptake by endothelial cells exposed to hypoxia/anoxia. Circulation Research 1987, 60:653-658.
99. Lee S.-D., Shroyer K.R., Markham N.E., Cool C.D., Voelkel N.F., Tuder R.M. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. The Journal of Clinical Investigation 1998, 101:927-934.
100. Lee S.L., Wang W.W., Lanzillo J.J., Fanburg B.L. Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. The American Journal of Physiology 1994, 266:L46-L52.
101. Lee S.L., Wang W.W., Moore B.J., Fanburg B.L. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circulation Research 1991, 68:1362-1368.
102. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
103. Liu Y., Suzuki Y.J., Day R.M., Fanburg B.L. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin. Circulation Research 2004, 95:579-586.
104. Long L., MacLean M.R., Jeffery T.K., Morecroft I., Yang X., Rudarakanchana N., et al. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circulation Research 2006, 98:818-827.
105. Lorenzoni A.G., Anthony N.B., Wideman R.F. Transpulmonary pressure gradient verifies pulmonary hypertension is initiated by increased arterial resistance in broilers. Poultry Science 2008, 87:125-132.
106. Louis W.J. Primary pulmonary hypertension and anorectic drugs. The New England Journal of Medicine 1999, 340:481-482.
107. Loyd J.E., Newman J.H. Familial primary pulmonary hypertension. Primary pulmonary hypertension 1997, 151-162. Marcel Dekker, Inc., New York, NY. L.J. Rubin, S. Rich (Eds.).
108. Lubritz D.L., Smith J.L., McPherson B.N. Heritability of ascites and the ratio of right to total ventricle weight in broiler breeder male lines. Poultry Science 1995, 74:1237-1241.
109. MacLean M., Hervé P., Eddahibi S., Adnot S. 5-Hydroxytryptamine and the pulmonary circulation: Receptors, transporters and relevance to pulmonary arterial hypertension. British Journal of Pharmacology 2000, 131:161-168.
110. MacLean M., Sweeney R.G., Baird M., McCulloch K.M., Houslay M., Morecroft I. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. British Journal of Pharmacology 1996, 119:917-930.
111. Maina J.N. Scanning electron microscope study of the spatial organization of air and blood conducting components of the avian lung (Gallus gallus variant domesticus). The Anatomical Record 1988, 222:145-153.
112. Marcos E., Adnot S., Pham M.H., Nosjean A., Raffestein B., Hamon M., et al. Serotonin transporter inhibitors protect against hypoxic pulmonary vasoconstriction. American Journal of Respiratory and Critical Care Medicine 2003, 168:487-493.
113. Marcos E., Fadel E., Sanchez O., Humbert M., Dartevelle P., Simonneau G., et al. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circulation Research 2004, 94:1263-1270.
114. Martinez-Lemus L.A., Hester R.K., Becker E.J., Jeffrey J.S., Odom T.W. Pulmonary artery endothelium-dependent vasodilation is impaired in a chicken model of pulmonary hypertension. The American Journal of Physiology 1999, 277:R190-R197.
115. Mason N.A., Springall D.R., Burke M., Pollack J., Mikhail G., Yacoub M.H., et al. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. The Journal of Pathology 1998, 185:313-318.
116. Maxwell M.H. Red cell size and various lung arterial measurements in different strains of domestic fowl. Research in Veterinary Science 1991, 50:233-239.
117. McGoon M.D., Vanhoutte P.M. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. The Journal of Clinical Investigation 1984, 74:828-833.
118. McLaughlin V.V. Pulmonary arterial hypertension: Current diagnosis and management. American College of Cardiology Current Journal Review 2002, 11(3):17-21.
119. Mecham R.P., Whitehouse L.A., Wrenn D.S., Parks W.C., Griffin G.L., Senior R.M., et al. Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science 1987, 237:423-426.
120. Medhora M., Bousamra M., Zhu D., Somberg L., Jacobs E.R. Upregulation of collagens detected by gene array in a model of flow-induced pulmonary vascular remodeling. American Journal of Physiology- Heart and Circulation Physiology 2002, 282:H414-H422.
121. Moghadam H.K., McMillan I., Chambers J.R., Julian R.J. Estimation of genetic parameters for ascites syndrome in broiler chickens. Poultry Science 2001, 80:844-848.
122. Morecroft I., Heeley R.P., Prentice H.M., Kirk A., MacLean M.R. 5-HT receptors mediating contraction in human small pulmonary arteries: Importance of the 5-HT1B receptor. British Journal of Pharmacology 1999, 128:730-734.
123. Moreno de Sandino M., Hernandez A. Nitric oxide synthase expression in the endothelium of pulmonary arterioles in normal and pulmonary hypertensive chickens subjected to chronic hypobaric hypoxia. Avian Disease 2003, 47:1291-1297.
124. Moreno de Sandino M., Hernandez A. Pulmonary arteriole remodeling in hypoxic broilers expressing different amounts of endothelial nitric oxide synthase. Poultry Science 2006, 85:899-901.
125. Morse J.H. Defining the role and clinical relevance of BMPR2 mutations in pulmonary arterial hypertension. Advances in Pulmonary Hypertension 2005, 4(1):5-12.
126. Naeije R., Eddahibi S. Serotonin in pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine 2004, 70:209-210.
127. Naeye R.L., Vennart G.P. The structure and significance of pulmonary plexiform structures. The American Journal of Pathology 1959, 36:593-605.
128. Nagaoka T., Gebb S.A., Karoor V., Homma N., Morris K.G., McMurtry I.F., et al. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat. Journal of Applied Physiology 2006, 100:996-1002.
129. Nauser T.D., Stites S.W. Diagnosis and treatment of pulmonary hypertension. American Family Physician 2001, 63(9):1789-1799.
130. Newman J.H., Trembath R.C., Morse J.A., Grunig E., Loyd J.E., Adnot S., et al. Genetic basis of pulmonary arterial hypertension. Journal of the American College of Cardiology 2004, 43:33S-39S.
131. Nicolls M.R., Taraseviciene-Stewart T., Rai P.R., Badesch D.B., Voelkel N.F. Autoimmunity and pulmonary hypertension: A perspective. The European Respiratory Journal 2005, 26:1110-1118.
132. Nishimura T., Faul J.L., Berry G.J., Vaszar L.T., Qui D., Pearl R.G., et al. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. American Journal of Respiratory and Critical Care Medicine 2002, 166:1403-1408.
133. Nishimura T., Vaszar L.T., Faul J.L., Zhao G., Berry G.M., Shi L., et al. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation 2003, 108:1640-1645.
134. Owen R.L., Wideman R.F., Barbato G.F., Cowen B.S., Ford B.C., Hattel A.L. Morphometric and histologic changes in the pulmonary system of broilers raised at simulated high altitude. Avian Pathology 1995, 24:293-302.
135. Owen R.L., Wideman R.F., Cowen B.S. Changes in pulmonary arterial and femoral arterial pressure upon acute exposure to hypobaric hypoxia in broiler chickens. Poultry Science 1995, 74:708-715.
136. Owen R.L., Wideman R.F., Hattel A.L., Cowen B.S. Use of a hypobaric chamber as a model system for investigating ascites in broilers. Avian Disease 1990, 34:754-758.
137. Owen R.L., Wideman R.F., Leach R.M., Cowen B.S., Dunn P.A., Ford B.C. Physiologic and electrocardiographic changes occurring in broilers reared at simulated high altitude. Avian Disease 1995, 39:108-115.
138. Pakala R., Willerson J.T., Benedict C.R. Mitogenic effect of serotonin on vascular endothelial cells. Circulation 1994, 90:1919-1926.
139. Pakdel A., Van Arendonk J.A.M., Vereijken A.L.J., Bovenhuis H. Direct and maternal genetic effects for ascites-related traits in broilers. Poultry Science 2002, 81:1273-1279.
140. Palevsky H.I., Schloo B.L., Pietra G.G., Weber K.T., Janicki J.S., Ruben E., et al. Primary pulmonary hypertension: Vascular structure, morphometry and responsiveness to vasodilator agents. Circulation 1989, 80:1207-1221.
141. Pan J.-Q., Tan X., Li J.-C., Sun W.-D., Wang X.-L. Effects of early feed restriction and cold temperature on lipid peroxidation, pulmonary vascular remodeling and ascites morbidity in broilers under normal and cold temperatures. British Poultry Science 2005, 46:374-381.
142. Peacock A.J., Pickett C., Morris K., Reeves J.T. The relationship between rapid growth and pulmonary hemodynamics in the fast-growing broiler chicken. The American Review of Respiratory Disease 1989, 139:1524-1530.
143. Peacock A.J., Pickett C., Morris K., Reeves J.T. Spontaneous hypoxaemia and right ventricular hypertrophy in fast growing broiler chickens reared at sea level. Comparative Biochemistry and Physiology 1990, 97A:537-541.
144. Pietra G.G. The pathology of primary pulmonary hypertension. Primary pulmonary hypertension: Lung biology in health and disease 1997, 19-61. Marcel Dekker, Inc., New York, NY. L.J. Rubin, S. Rich (Eds.).
145. Pietra G.G., Capron F., Stewart S., Leone O., Humbert M., Robbins I.M., et al. Pathologic assessment of vasculopathies in pulmonary hypertension. Journal of the American College of Cardiology 2004, 43:25S-32S.
146. Pitt B.R., Weng W., Steve A.R., Blakely R.D., Reynolds I., Davies P. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. The American Journal of Physiology 1994, 266:L178-L186.
147. Ploog, H. P. (1973). Physiologic changes in broiler chickens (Gallus domesticus) exposed to a simulated altitude of 4267m (14000ft). M.S. Thesis, The Pennsylvania State University, University Park, PA.
148. Rabinovitch M. Insights into the pathogenesis of primary pulmonary hypertension from animal models. Primary pulmonary hypertension 1997, 63-82. Marcel Dekker, Inc., New York, NY. L.J. Rubin, S. Rich (Eds.).
149. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:2542-2546.
150. Rich S. Clinical insights into the pathogenesis of primary pulmonary hypertension. Chest 1998, 114:237S-241S.
151. Richter A., Yeager M.E., Zaiman A., Cool C.D., Voelkel N.F., Tuder R.M. Impaired transforming growth factor-β signaling in idiopathic pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine 2004, 170:1340-1348.
152. Rodat-Despoix L., Crevel H., Marthan R., Savineau J.O.P., Guibert C. Heterogeneity in 5HT-induced contractile and proliferative responses in rat pulmonary arterial bed. Journal of Vascular Research 2008, 45:181-192.
153. Rothman R.B., Ayestas M.A., Dersch C.M., Bauman M.H. Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation 1999, 100:869-875.
154. Rubin L.J. Primary pulmonary hypertension. The New England Journal of Medicine 1997, 336:111-117.
155. Russell B.R., Laverty R. Correlation between 5-HT content and uptake site density following (S)-MDMA and dexfenfluramine-induced depletion, and with neuroprotection by the glycine site-specific NMDA antagonist ACEA 1021. Annals of the New York Academy of Sciences 2000, 914:208-214.
156. Sakao S., Taraseviciene-Stewart L., Lee J.D., Wood K., Cool C.D., Voelkel N.F. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. The Journal of the Federation of American Societies for Experimental Biology 2005, 19:1178-1180.
157. Saldana M.E., Harley R.A., Liebow A.A., Carrington C.B. Experimental extreme pulmonary hypertension and vascular disease in relation to polycythemia. The American Journal of Pathology 1968, 52:935-981.
158. Sato K., Webb S., Tucker A., Rabinovitch M., O'Brien R.F., McMurtry I.F., et al. Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. The American Review of Respiratory Disease 1992, 145:793-797.
159. Schnader S.M., Schloo B.L., Anderson W., Stephenson L.W., Fishman A.P. Chronic pulmonary hypertension in sheep: Temporal progression of lesions. The Journal of Surgical Research 1996, 62:243-250.
160. Seiler K.U., Wassermann O., Wensky H. On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs, an experimental study in the isolated perfused rat lung. Clinical and Experimental Pharmacology & Physiology 1974, 1:463-471.
161. Sibbald W., Peters S., Lindsay R.M. Serotonin and pulmonary hypertension in human septic ARDS. Critical Care Medicine 1980, 8:490-494.
162. Sillau A.H., Montalvo C. Pulmonary hypertension and the smooth muscle of pulmonary arterioles in chickens at high altitude. Comparative Biochemistry and Physiology 1982, 71A:125-130.
163. Silversides F.G., LeFrancois M.R., Villeneuve P. The effect of strain of broiler on physiological parameters associated with the ascites syndrome. Poultry Science 1997, 76:663-667.
164. Simoneit L.W., Belamarich F.A., Shepro D. The localization of 5-hydroxytryptamine in blood cells in nonmammalian vertebrates. The Journal of Cell Biology 1970, 47:192-193.
165. Simonneau G., Galie N., Rubin L.J., Langleben D., Seeger W., Domenighetti G., et al. Clinical classification of pulmonary hypertension. Journal of the American College of Cardiology 2004, 43:5S-12S.
166. Sorimachi M., Kataoka K., Inouye A. Uptake of 5-hydroxytryptamine by domestic fowl thrombocytes (spindle cells) in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology 1974, 283:53-65.
167. Sorimachi M., Kataoka K., Inouye A., Hori S. Release in vitro of 5-hydroxytryptamine from spindle cells of the domestic fowl. European Journal of Pharmacology 1970, 10:243-248.
168. Stelzner T.J., O'Brien R.F., Sato K., Webb S., Zamora M.R., Sakurai T., et al. Increased endothelin-1 expression in rats with pulmonary hypertension. The American Journal of Physiology 1992, 262:L614-L620.
169. Stenmark K.R., Meyrick B., Galie N., Mooi W.J., McMurtry I.F. Animal models of pulmonary arterial hypertension: The hope for etiological discovery and pharmacological cure. American Journal of Physiology. Lung Cellular and Molecular Physiology 2009, 297:L1013-L1032.
170. Stevens T. Molecular and cellular determinants of lung endothelial cell heterogeneity. Chest 2005, 128:558-564.
171. Stevens T., Rosenberg R., Aird W., Quertermous T., Johnson F.J., Garcia J.G.N., et al. NHLBI workshop report: Endothelial cell phenotypes in heart, lung, and blood diseases. American Journal of Physiology. Cell Physiology 2001, 281:C1422-C1433.
172. Sullivan C.C., Du L., Chu D., Cho A.J., Kido M., Wolf P.L., et al. Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:12331-12336.
173. Tan X., Liu Y.-J., Li J.-C., Pan J.-Q., Sun W.-D., Wang X.-L. Activation of PCKα and pulmonary vascular remodeling in broilers. Research in Veterinary Science 2005, 79:131-137.
174. Tan X., Pan J.-Q., Li J.-C., Liu Y.-J., Sun W.-D., Wang X.-L. l-Arginine inhibiting pulmonary vascular remodelling is associated with promotion of apoptosis in pulmonary arterioles smooth muscle cells in broilers. Research in Veterinary Science 2005, 79:203-209.
175. Tanaka Y., Schuster D.P., Davis E.C., Patterson G.A., Botney M.D. The role of vascular injury and hemodynamics in rat pulmonary artery remodeling. The Journal of Clinical Investigation 1996, 98:434-442.
176. Taraseviciene-Stewart L., Kasahara Y., Alger L., Hirth P., Mc Mahon G., Waltenberger J., et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. The Journal of the Federation of American Societies for Experimental Biology 2001, 15:427-438.
177. Taraseviciene-Stewart L., Scerbavicius R., Choe K.-H., Cool C., Wood K., Tuder R.M., et al. Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology 2006, 291:L668-L676.
178. Tuder R.M., Chacon M., Alger L., Wang J., Taraseviciene-Stewart L., Kasahara Y., et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: Evidence for a process of disordered angiogenesis. The Journal of Pathology 2001, 195:367-374.
179. Tuder R.M., Cool C.D., Geraci M.W., Wang J., Abman S.H., Wright L., et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 1999, 159:1925-1932.
180. Tuder R.M., Groves B., Badesch D.B., Voelkel N.F. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. The American Journal of Pathology 1994, 144:275-285.
181. Tuder R.M., Lee S.-D., Cool C.C. Histopathology of pulmonary hypertension. Chest 1998, 114:1S-6S.
182. Tuder R.M., Radisavljevic Z., Shroyer K.R., Polak J.M., Voelkel N.F. Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 1998, 158:1999-2001.
183. Tyler R.C., Muramatsu M., Abman S.H., Selzner T.J., Rodman D.M., Bloch K.D., et al. Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension. The American Journal of Physiology 1999, 276:L297-L303.
184. Uzun O., Demiryurek A.T., Kanzik I. The role of tyrosine kinase in hypoxic constriction of sheep pulmonary artery rings. European Journal of Pharmacology 1998, 358:41-47.
185. Vaszar L.T., Nishimura T., Storey J.D., Zhao G., Qui D., Faul J.L., et al. Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats. Physiological Genomics 2004, 17:150-156.
186. Villamor E., Ruijtenbeek K., Pulgar V., De Mey J.G.R., Blanco C.E. Vascular reactivity in intrapulmonary arteries of chicken embryos during transition to ex ovo life. The American Journal of Physiology 2002, 282:R917-R927.
187. Voelkel N.F., Cool C., Lee S.D., Wright L., Geraci M.W., Tuder R.M. Primary pulmonary hypertension between inflammation and cancer. Chest 1998, 114:225S-230S.
188. Voelkel N.F., Tuder R.M., Weir E.K. Pathophysiology of primary pulmonary hypertension: From physiology to molecular mechanisms. Primary pulmonary hypertension 1997, 83-129. Marcel Dekker, Inc., New York, NY. L.J. Rubin, S. Rich (Eds.).
189. Wagenvoort C.A., Wagenvoort N. Primary pulmonary hypertension: A pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation 1970, 42:1163-1184.
190. Wang W., Wideman R.F., Bersi T.K., Erf G.F. Pulmonary and hematological inflammatory responses to intravenous cellulose micro-particles in broilers. Poultry Science 2003, 82:771-780.
191. Weir E.K., Reeve H.L., Huang J.M., Michelakis E., Nelson D.P., Hampl V., et al. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation 1996, 94:2216-2220.
192. Wideman R.F. Cardiac Output in four-, five- and six-week-old broilers, and hemodynamic responses to intravenous injections of epinephrine. Poultry Science 1999, 78:392-403.
193. Wideman R.F. Cardio-pulmonary hemodynamics and ascites in broiler chickens. Avian and Poultry Biology Reviews 2000, 11(1):21-43.
194. Wideman R.F. Pathophysiology of heart/lung disorders: Pulmonary hypertension syndrome in broiler chickens. World's Poultry Science Journal 2001, 57:289-307.
195. Wideman R.F., Bowen O.T., Erf G.F., Chapman M.E. Influence of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on the pulmonary hypertensive response to micro-particle injections in broilers. Poultry Science 2006, 85:511-527.
196. Wideman R.F., Chapman M.E., Hamal K.R., Bowen O.T., Lorenzoni A.G., Erf G.F., et al. An inadequate pulmonary vascular capacity and susceptibility to pulmonary arterial hypertension in broilers. Poultry Science 2007, 86:984-998.
197. Wideman R.F., Chapman M.E., Owens C.M., Devabhaktuni M.K., Cavitt L.C., Erf G.F. Broiler survivors of intravenous micro-particle injections: Evaluation of growth, livability, meat quality, and arterial blood gas values during a cyclic heat challenge. Poultry Science 2003, 82:484-495.
198. Wideman R.F., Chapman M.E., Wang W., Erf G.F. Immune modulation of the pulmonary hypertensive response to bacterial lipopolysaccharide (endotoxin) in broilers. Poultry Science 2004, 83:624-637.
199. Wideman R.F., Eanes M.L., Hamal K.R., Anthony N.B. Pulmonary vascular pressure profiles in broilers selected for susceptibility to pulmonary hypertension syndrome: Age and gender comparisons. Poultry Science 2010, 89:1815-1824.
200. Wideman R.F., Erf G.F. Intravenous micro-particle injections trigger pulmonary hypertension in broiler chickens. Poultry Science 2002, 81:877-886.
201. Wideman R.F., Erf G.F., Chapman M.E. Nω-Nitro-l-Arginine Methyl Ester (L-NAME) amplifies the pulmonary hypertensive response to micro-particle injections in broilers. Poultry Science 2005, 84:1077-1091.
202. Wideman R.F., Erf G.F., Chapman M.E., Wang W., Anthony N.B., Xiaofong L. Intravenous micro-particle injections and pulmonary hypertension in broiler chickens: Acute post-injection mortality and ascites susceptibility. Poultry Science 2002, 81:1203-1217.
203. Wideman R.F., Fedde M.R., Tackett C.D., Weigle G.E. Cardio-pulmonary function in preascitic (hypoxemic) or normal broilers inhaling ambient air or 100% oxygen. Poultry Science 2000, 79:415-425.
204. Wideman R.F., French H. Broiler breeder survivors of chronic unilateral pulmonary artery occlusion produce progeny resistant to pulmonary hypertension syndrome (ascites) induced by cool temperatures. Poultry Science 1999, 78:404-411.
205. Wideman R.F., French H. Ascites resistance of progeny from broiler breeders selected for two generations using chronic unilateral pulmonary artery occlusion. Poultry Science 2000, 79:396-401.
206. Wideman R.F., Kirby Y.K. A pulmonary artery clamp model for inducing pulmonary hypertension syndrome (ascites) in broilers. Poultry Science 1995, 74:805-812.
207. Wideman R.F., Kirby Y.K. Evidence of a ventilation-perfusion mismatch during acute unilateral pulmonary artery occlusion in broilers. Poultry Science 1995, 74:1209-1217.
208. Wideman R.F., Kirby Y.K., Owen R.L., French H. Chronic unilateral occlusion of an extra-pulmonary primary bronchus induces pulmonary hypertension syndrome (ascites) in male and female broilers. Poultry Science 1997, 76:400-404.
209. Wideman R.F., Kirby Y.K., Tackett C.D., Marson N.E., McNew R.W. Cardio-pulmonary function during acute unilateral occlusion of the pulmonary artery in broilers fed diets containing normal or high levels of arginine-HCl. Poultry Science 1996, 75:1587-1602.
210. Wideman R.F., Kirby Y.K., Tackett C.D., Marson N.E., Tressler C.J., McNew R.W. Independent and simultaneous unilateral occlusion of the pulmonary artery and extra-pulmonary primary bronchus in broilers. Poultry Science 1996, 75:1417-1427.
211. Wideman, R.F., Hamal, K.R., Bayona, M.T., Lorenzoni, A.G., Cross, D., Khajali, F. et al. (in press). Plexiform lesions in the lungs of domestic fowl selected for susceptibility to pulmonary arterial hypertension: Incidence and histology. The Anatomical Record.
212. Wright L., Tuder R.M., Wang J., Cool C.D., Lepley R.A., Voelkel N.F. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 1998, 157:219-229.
213. Xiang R.P., Sun W.D., Wang J.Y., Wang X.L. Effect of vitamin C on pulmonary hypertension and muscularization of pulmonary arterioles in broilers. British Poultry Science 2002, 43:705-712.
214. Xiang R.P., Sun W.D., Zhang K.C., Li J.C., Wang J.Y., Wang X.L. Sodium chloride-induced acute and chronic pulmonary hypertension syndrome in broiler chickens. Poultry Science 2004, 83:732-736.
215. Yamaki S., Wagenvoort C.A. Comparison of primary plexogenic arteriopathy in adults and children. British Heart Journal 1985, 54:428-434.
216. Yi E.S., Kim H., Ahn H., Strother J., Morris T., Masliah E., et al. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 2000, 162:1577-1586.
217. Zabka T.S., Campbell F.E., Wilson D.W. Pulmonary arteriopathy and idiopathic pulmonary arterial hypertension in six dogs. Veterinary Pathology 2006, 43:510-522.
218. Zamora M.R., Stelzner T.J., Webb S., Panos R.J., Ruff L.J., Dempsey E.C. Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. The American Journal of Physiology 1996, 270:L101-L109.